Abstract
Through this commentary, we attempt to evaluate the success of the Algerian legislature in developing a legal framework for the pharmaceutical industry that protects public health. The study is based on Algeria's national legal framework for the pharmaceutical industry, namely, legislation on health law and regulations on pharmaceutical activity. The study focuses on legal texts and uses the method of comparison whenever necessary. Algeria has established an integrated system for regulating the pharmaceutical industry at the national level. Algeria reserves its right to intervene in pharmaceutical economic activity through national industrial institutions. At the same time, Algeria allows private Algerian or foreign companies to become active in the pharmaceutical industry. However, the pharmaceutical industry sector has not freed the country from dependence on imports from abroad. Public authorities should provide continuous information about the support and facilities provided to pharmaceutical investors.